论文信息 - First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients - 字舞流文

First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients

Jinzi J. Wu | Zhicheng Zhang | Hongyi Chen | Yahong Chen | Xiaodong Li | Zhihua Huang | Li Wang | Fanghua Gong